Glencoe, Aridhia team to develop life sciences tech

With the potential for breakthroughs in the lab to revolutionize medicine, Glencoe Software and Aridhia Informatics are combining resources to advance new technology products to support personalized treatment development and better patient care.

Dundee, Scotland-based Aridhia is making a "major investment" of an undisclosed amount in Glencoe, which is headquartered in Seattle. Glencoe develops software products with open-source technology from the Open Microscopy Environment (OME) and will bring to the partnership know-how in "managing, sharing and publishing large scientific datasets generated in laboratories around the world," the company said in a release. For its part, Aridhia plans to complement those capabilities with its expertise in "accessing, storing and analyzing healthcare information."

"OME and Glencoe Software are particularly excited about this partnership," Jason Swedlow, president of Glencoe Software and co-founder of OME. "We look forward to working with the Aridhia Informatics team to develop new tools for the life sciences and clinical data markets. The challenge is huge, but the potential benefit for biomedical research and patient outcomes is enormous."

While their businesses are incorporated in different countries, Aridhia and Glencoe were both formed with technology from the University of Dundee in Scotland.

- here's the release
- see the news in the Edinburgh Evening News
- and the report in GenomeWeb

NextDocs opens door to VC with $10.3M funding
PharmaPros teams up with Soltex, extends pharma reach

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.